As of 2025-12-20, the Relative Valuation of Knight Therapeutics Inc (GUD.TO) is 1.70 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 6.03 CAD, the upside of Knight Therapeutics Inc based on Relative Valuation is -71.8%.
The range of the Relative Valuation is (0.05) - 5.02 CAD.
| Range | Selected | |
| Trailing P/E multiples | 1.3x - 4.8x | 3.0x |
| Forward P/E multiples | 19.9x - 50.0x | 35.0x |
| Fair Price | (0.05) - 5.02 | 1.70 |
| Upside | -100.7% - -16.7% | -71.8% |
| Date | P/E |
| 2025-12-18 | -171.69 |
| 2025-12-17 | -171.41 |
| 2025-12-16 | -172.83 |
| 2025-12-15 | -170.84 |
| 2025-12-12 | -172.54 |
| 2025-12-11 | -172.83 |
| 2025-12-10 | -171.41 |
| 2025-12-09 | -168.28 |
| 2025-12-08 | -168.85 |
| 2025-12-05 | -171.97 |
| 2025-12-04 | -171.97 |
| 2025-12-03 | -171.69 |
| 2025-12-02 | -171.12 |
| 2025-12-01 | -172.26 |
| 2025-11-28 | -171.97 |
| 2025-11-27 | -172.54 |
| 2025-11-26 | -171.97 |
| 2025-11-25 | -171.12 |
| 2025-11-24 | -171.41 |
| 2025-11-21 | -173.96 |
| 2025-11-20 | -172.26 |
| 2025-11-19 | -174.25 |
| 2025-11-18 | -173.68 |
| 2025-11-17 | -174.25 |
| 2025-11-14 | -174.53 |
| 2025-11-13 | -174.82 |
| 2025-11-12 | -177.37 |
| 2025-11-11 | -177.09 |
| 2025-11-10 | -171.97 |
| 2025-11-07 | -171.97 |
| 2025-11-06 | -172.54 |
| 2025-11-05 | -166.00 |
| 2025-11-04 | -164.87 |
| 2025-11-03 | -166.00 |
| 2025-10-31 | -166.00 |
| 2025-10-30 | -164.87 |
| 2025-10-29 | -163.45 |
| 2025-10-28 | -165.72 |
| 2025-10-27 | -166.57 |
| 2025-10-24 | -165.72 |
| 2025-10-23 | -166.86 |
| 2025-10-22 | -164.87 |
| 2025-10-21 | -166.57 |
| 2025-10-20 | -167.14 |
| 2025-10-17 | -164.30 |
| 2025-10-16 | -164.30 |
| 2025-10-15 | -163.45 |
| 2025-10-14 | -163.45 |
| 2025-10-10 | -164.01 |
| 2025-10-09 | -167.43 |